MOLE', Daniela
 Distribuzione geografica
Continente #
NA - Nord America 2.233
EU - Europa 710
AS - Asia 560
SA - Sud America 42
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 3.553
Nazione #
US - Stati Uniti d'America 2.227
CN - Cina 245
SG - Singapore 207
UA - Ucraina 161
PL - Polonia 136
DE - Germania 128
IT - Italia 87
TR - Turchia 86
GB - Regno Unito 64
FI - Finlandia 63
SE - Svezia 44
BR - Brasile 36
CA - Canada 6
RU - Federazione Russa 6
AT - Austria 5
BE - Belgio 5
FR - Francia 4
ID - Indonesia 4
IQ - Iraq 4
AR - Argentina 3
BD - Bangladesh 3
EU - Europa 3
HK - Hong Kong 3
LT - Lituania 3
NL - Olanda 3
VN - Vietnam 3
CL - Cile 2
JO - Giordania 2
MA - Marocco 2
DZ - Algeria 1
EC - Ecuador 1
IR - Iran 1
KE - Kenya 1
NZ - Nuova Zelanda 1
OM - Oman 1
PK - Pakistan 1
PT - Portogallo 1
Totale 3.553
Città #
Woodbridge 268
Chandler 205
Fairfield 199
Ashburn 194
Jacksonville 185
Houston 162
Warsaw 136
Ann Arbor 132
Santa Clara 127
Singapore 125
Wilmington 85
Seattle 75
Cambridge 65
Addison 52
Nanjing 44
Beijing 42
Izmir 42
Princeton 35
Boardman 32
Helsinki 30
Shanghai 26
Dearborn 25
Ferrara 25
Milan 22
Bremen 20
San Diego 17
Shenyang 17
Jinan 15
Los Angeles 15
Mountain View 13
Nanchang 12
New York 11
Nuremberg 11
Washington 10
Tianjin 9
Hebei 8
Jiaxing 8
L’Aquila 8
Auburn Hills 7
Changsha 7
Frankfurt am Main 6
Orange 6
Rome 6
Brussels 5
Guangzhou 5
Indiana 5
London 5
Norwalk 5
Cagliari 4
Jakarta 4
Ningbo 4
Redwood City 4
Tappahannock 4
Augusta 3
Chengdu 3
Dong Ket 3
Falls Church 3
Hefei 3
Kunming 3
Lanzhou 3
Leawood 3
Munich 3
Padova 3
Taizhou 3
Vienna 3
Amman 2
Baghdad 2
Bariloche 2
Bologna 2
Catanzaro 2
Dhaka 2
Hangzhou 2
Hong Kong 2
Kingston 2
Osasco 2
Ottawa 2
Presidente Prudente 2
São Sebastião do Paraíso 2
Taiyuan 2
Toronto 2
Araguaína 1
Ardabil 1
Belford Roxo 1
Blida 1
Brasília 1
Canaro 1
Canoas 1
Casablanca 1
Catalão 1
Changchun 1
Chittagong 1
Conceição do Coité 1
Des Moines 1
Dom Eliseu 1
Dongguan 1
Falkenstein 1
Foz do Iguaçu 1
Fuzhou 1
Guarabira 1
Guiyang 1
Totale 2.670
Nome #
PKC COME NUOVO TARGET MOLECOLARE NEL CONTROLLO DELLA PROLIFERAZIONE CELLULARE DEI TUMORI NEUROENDOCRINI 186
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 167
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 158
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 138
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 138
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 131
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 130
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 129
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 127
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 127
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. 126
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 124
Growth hormone excess promotes breast cancer chemoresistance 124
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 117
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 103
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 100
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 100
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 100
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 94
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 90
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 88
ctivation of EGFR promotes ACC cell proliferation by inducing VEGF autocrine secretion 88
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 86
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 85
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 82
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures 79
Mitotane reduces the chemoresistance phenotype in an adrenocortical carcinoma cell line 78
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 77
Targeting PKC in human pancreatic neuroendocrine tumor cells 76
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 72
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 67
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 62
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 62
null 40
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  32
Totale 3.583
Categoria #
all - tutte 16.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.835


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020122 0 0 0 0 0 0 0 0 0 82 28 12
2020/2021416 39 33 16 74 9 50 10 53 5 51 60 16
2021/2022313 13 28 15 3 13 18 10 8 8 34 43 120
2022/2023422 39 39 20 55 77 52 19 36 57 0 15 13
2023/2024252 21 22 11 9 16 41 9 77 3 3 2 38
2024/2025569 22 19 58 18 122 125 25 18 100 62 0 0
Totale 3.583